FDA Approves First Generics of Gilenya
December 05, 2019 -- The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis(MS) in adult
FDA Approves Avsola
FDA Approves Avsola (infliximab-axxq), a Biosimilar to Remicade
THOUSAND OAKS, Calif., Dec. 6, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Avsola (inflixima
FDA Approves Genentech’s Tecentriq Plus Chemotherapy (Abraxane and Carboplatin) for The Initial Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer
South San Francisco, CA -- December 3, 2019 -- Genentech, a member of the Roche Group (SIX: RO
Cancer Patients Need More Info on Side Effects of Radiation Tx
WEDNESDAY, Nov. 27, 2019 -- Although most cancer patients do not experience anticipated potential adverse effects of radiation therapy, more than one-third have adverse effects that they wish
Sex Isnt Always What Drives Sexting
FRIDAY, Nov. 29, 2019 -- "Sexting" may sound salacious, but it isnt always about sex, a new study shows.
In fact, two-thirds of adults who send these sexually oriented text messages dont have sex in mind at all, the
Leg Pain Could Spell Peripheral Artery Disease for Some
FRIDAY, Nov. 29, 2019 -- Leg pain while walking or doing other activities could be a sign of peripheral artery disease, an expert says.
Peripheral artery disease (PAD) develops silently, narrow